Berlin Heart continues to support godchildren in Africa
In 2011, the sponsorships for supporting Nancy, Nyapal Temesgen and Emmanuel shall continue with financial commitment from our employees.
(firmenpresse) - In 2011, the sponsorships for supporting Nancy, Nyapal Temesgen and Emmanuel shall continue with financial commitment from our employees.
“We consider it our moral duty to not only support children and adults around the world with our products, but to also give our godchildren the opportunity of a better life,” says the managing director of the Berlin Heart GmbH Dr. Stefan Thamasett.
Since 2010 Berlin Heart has been sponsoring children from various countries in Africa, to facilitate their difficult life and help to put a smile on their faces.
The children who originate from Sudan, Ethiopia, Zambia and Uganda have been struck by bad fate and depend on the support of the SOS Children's Villages and their new families. This provides them with energy to forget the past and to look into a brighter future.
Berlin Heart is happy to bring a shine to these children’s eyes and wishes all customers and suppliers
a Happy New Year 2011.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
About Berlin Heart
Berlin Heart GmbH is the only company worldwide that develops, produces and distributes implantable and external ventricular assist devices for patients of every age and body size.
The company offers pumps, cannulae, and external components for internal and external use to stabilise cardiac activity in acutely ill patients. Its products are market leaders in their respective segments in Germany and in Europe.
About EXCOR®
EXCOR® is a paracorporeal ventricular assist device for patients of all age groups, from newborns to adults. It is used for short-, mid- and long-term cardiac support and can support failing hearts for any duration from a couple of days to several months and years. Since the first implantation in 1988 EXCOR® has been implanted in more than 2.000 patients worldwide.
About INCOR®
The company also manufactures the implantable left ventricular assist device INCOR®, which has been designed for long-term application in adult patients. The longest the device has supported a patient so far is more than five years and ongoing.
EXCOR® is currently under clinical investigation for pediatric use in USA. All other products are not FDA approved.
Datum: 25.01.2011 - 11:30 Uhr
Sprache: Deutsch
News-ID 1021201
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Phone:
Kategorie:
Healthcare & Medical
Anmerkungen:
Diese Pressemitteilung wurde bisher 425 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Berlin Heart continues to support godchildren in Africa
"
steht unter der journalistisch-redaktionellen Verantwortung von
Berlin Heart GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
